Market
What changes will occur in NIH leadership under Trump administration by end of 2025?
2
Donald Trump•Jay Bhattacharya•National Institutes of Health•NIH•Bhattacharya•Stanford University•Nobel•Health•Human Services•Republicans•Kennedy•Libertarians•Trump
Resolution / Starting Odds
Bhattacharya confirmed as Director • 25%
Interim Director appointed • 25%
New nominee proposed • 25%
No change in leadership • 25%
Official announcements from the NIH or U.S. government
Story
Trump's NIH Director Nominee Faces Opposition from 75 Nobel Laureates
Dec 11, 2024, 01:53 PM
President-elect Donald Trump has nominated Dr. Jay Bhattacharya to head the National Institutes of Health (NIH), aiming to address the chronic disease crisis in the U.S. Bhattacharya, a professor at Stanford University, has been described as an 'eminently qualified person' by some supporters. His appointment is viewed as a potential shift towards focusing on prevention and reversing chronic diseases. However, this nomination has sparked controversy, with over 75 Nobel laureates expressing concerns about the implications for health research and policy. Critics worry that Bhattacharya's views on vaccines and health could lead to the promotion of debunked claims linking vaccines to autism. Additionally, Robert F. Kennedy Jr. has been considered for the position of Secretary of Health and Human Services, raising further concerns among pro-life Republicans due to his pro-abortion stance. Kennedy has also been involved in a fundraising deal with Libertarians, which has provided a financial boost to his campaign and Trump's.
View original story
Similar markets
Confirmed • 25%
Withdrawn • 25%
Delayed • 25%
Rejected • 25%
Unclear • 25%
No change • 25%
Less restrictive • 25%
More restrictive • 25%
Both Director and Deputy Director replaced • 25%
New Deputy Director appointed • 25%
New Director appointed • 25%
No leadership changes • 25%
Greater state government autonomy • 25%
Strengthened Congressional authority • 25%
Increased Presidential power • 25%
Status quo maintained • 25%
Other leadership changes • 25%
No change in leadership • 25%
New acting director appointed • 25%
Caleb Vitello confirmed as permanent director • 25%
Judicial Branch • 25%
Executive Branch • 25%
Legislative Branch • 25%
No significant changes • 25%
Mixed changes • 25%
Stricter policies • 25%
Looser policies • 25%
No change • 25%
Other • 25%
Narrower focus on infectious diseases • 25%
Continued broad public health focus • 25%
Increased focus on vaccine safety • 25%
New international alliances • 25%
No significant changes • 25%
Increased border security • 25%
Military action • 25%
Funding cuts • 25%
Increased oversight • 25%
Other actions • 25%
No change • 25%
Major changes enacted • 25%
Policies reversed by courts • 25%
No changes enacted • 25%
Minor changes enacted • 25%